Raymond James vs ORIX
Diversified US financial services firm with wealth management vs Japanese diversified financial services group with global real estate. Which is the better buy for your portfolio in May 2026? Plain-English answer below.
Raymond James is a US-based full-service wealth management and investment banking firm growing its advisor headcount and client assets aggressively, while ORIX is a Japanese financial conglomerate spanning leasing, banking, insurance, real estate, and private equity globally. Both generate diverse financial services revenue with meaningful fee components. Raymond James vs ORIX compares a focused American wealth manager with a sprawling Japanese financial conglomerate on return on equity, geographic risk, and earnings consistency.
Raymond James is a US-based full-service wealth management and investment banking firm growing its advisor headcount and client assets aggressively, while ORIX is a Japanese financial conglomerate spa...
Why It's Moving
Raymond James is edging higher as fresh analyst updates point to modest upside and a stable outlook.
- Morgan Stanley lifted its target to $185 from $184 and kept an Equalweight stance, reinforcing the view that analysts see limited near-term downside but only measured upside.
- BofA, Keefe Bruyette & Woods, BMO Capital, and Citizens also raised targets, suggesting broader confidence in Raymond Jamesβ earnings resilience and growth mix.
- Recent analyst commentary has pointed to wealth management strength, advisor recruiting, and a possible recovery in capital markets as the main drivers supporting sentiment.
IX is under pressure as analyst caution points to limited near-term upside and a modest pullback risk.
- Recent trading has been choppy, suggesting investors are waiting for a clearer catalyst before assigning a higher valuation.
- The downside warning implies analysts see the current share price as vulnerable if momentum fades or buyers step aside.
- With no major earnings surprise or fresh corporate update in the last seven days, broader market and sector sentiment are doing most of the work on the stock.
Raymond James is edging higher as fresh analyst updates point to modest upside and a stable outlook.
- Morgan Stanley lifted its target to $185 from $184 and kept an Equalweight stance, reinforcing the view that analysts see limited near-term downside but only measured upside.
- BofA, Keefe Bruyette & Woods, BMO Capital, and Citizens also raised targets, suggesting broader confidence in Raymond Jamesβ earnings resilience and growth mix.
- Recent analyst commentary has pointed to wealth management strength, advisor recruiting, and a possible recovery in capital markets as the main drivers supporting sentiment.
IX is under pressure as analyst caution points to limited near-term upside and a modest pullback risk.
- Recent trading has been choppy, suggesting investors are waiting for a clearer catalyst before assigning a higher valuation.
- The downside warning implies analysts see the current share price as vulnerable if momentum fades or buyers step aside.
- With no major earnings surprise or fresh corporate update in the last seven days, broader market and sector sentiment are doing most of the work on the stock.
Investment Analysis
Pros
- Raymond James reported record client assets of $1.73 trillion, reflecting strong market share and client confidence.
- The company achieved robust year-on-year revenue growth of 8% and maintained a high gross profit margin above 93%.
- Raymond James has consistently increased dividends for 41 consecutive years, demonstrating reliable shareholder returns.
Considerations
- The stock trades at a premium valuation relative to peers, with a forward P/E above the sector average.
- Revenue and earnings are highly sensitive to US capital markets activity, exposing the company to cyclical risks.
- Recent analyst price targets suggest limited upside, with some forecasts indicating only modest growth over the next year.
ORIX
IX
Pros
- ORIX maintains a diversified global business model spanning leasing, banking, insurance, and asset management.
- The company has a strong balance sheet with low leverage and consistent cash flow generation from core operations.
- ORIX benefits from exposure to high-growth sectors such as renewable energy and infrastructure in Asia and the Americas.
Considerations
- ORIX's earnings are exposed to fluctuations in foreign exchange rates due to its international operations.
- The company faces competitive pressures in its core leasing and financial services markets, particularly in Japan.
- Regulatory changes in key markets, including Japan and the US, could impact profitability and expansion plans.
Raymond James (RJF) Next Earnings Date
The next earnings date for RJF is Wednesday, July 22, 2026, based on the companyβs typical reporting pattern. The release is expected after the market close and will cover fiscal Q3 2026. Raymond James has not formally confirmed the date yet, so it should be treated as an estimated earnings window rather than a fixed announcement.
ORIX (IX) Next Earnings Date
The next earnings date for IX is August 7, 2026 based on the latest estimated schedule. This report is expected to cover Q1 fiscal 2027 for ORIX Corp ADR, following the companyβs customary reporting pattern. If the date is not formally announced, that timing remains the most likely market estimate for the next release.
Raymond James (RJF) Next Earnings Date
The next earnings date for RJF is Wednesday, July 22, 2026, based on the companyβs typical reporting pattern. The release is expected after the market close and will cover fiscal Q3 2026. Raymond James has not formally confirmed the date yet, so it should be treated as an estimated earnings window rather than a fixed announcement.
ORIX (IX) Next Earnings Date
The next earnings date for IX is August 7, 2026 based on the latest estimated schedule. This report is expected to cover Q1 fiscal 2027 for ORIX Corp ADR, following the companyβs customary reporting pattern. If the date is not formally announced, that timing remains the most likely market estimate for the next release.
Buy RJF or IX in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
